Bausch Health to Announce Third Quarter 2025 Results on October 29
Bausch Health (NYSE:BHC) has scheduled its third quarter 2025 financial results announcement for October 29, 2025, after market close. The company will host a conference call and webcast at 5:00 p.m. U.S. EDT to discuss the results and provide a business update.
All presentation materials will be available on the company's Investor Relations website before the call begins. A replay of the conference call will also be accessible through the investor relations website at ir.bauschhealth.com.
Bausch Health (NYSE:BHC) ha programmato l'annuncio dei risultati finanziari del terzo trimestre 2025 per 29 ottobre 2025, dopo la chiusura del mercato. L'azienda organizzerà una conference call e una webcast alle 17:00, ora legale degli Stati Uniti (EDT), per discutere i risultati e fornire un aggiornamento sull'attività.
Tutti i materiali della presentazione saranno disponibili sul sito della Relazioni con gli Investitori dell'azienda prima dell'inizio della chiamata. Una registrazione della conference call sarà disponibile anche sul sito delle relazioni con gli investitori all'indirizzo ir.bauschhealth.com.
Bausch Health (NYSE:BHC) ha programado el anuncio de resultados financieros del tercer trimestre de 2025 para el 29 de octubre de 2025, después del cierre del mercado. La empresa organizará una conferencia telefónica y una transmisión web a las 5:00 p.m. EDT para analizar los resultados y proporcionar una actualización comercial.
Todos los materiales de la presentación estarán disponibles en el sitio web de Relaciones con Inversores de la empresa antes de que comience la llamada. Una repetición de la conferencia también estará disponible a través del sitio web de relaciones con inversores en ir.bauschhealth.com.
Bausch Health (NYSE:BHC)가 2025년 3분기 실적 발표를 2025년 10월 29일에 장 마감 후로 예정했습니다. 회사는 결과를 논의하고 사업 업데이트를 제공하기 위해 미국 동부 표준시(EDT) 기준 오후 5시의 컨퍼런스콜과 웹캐스트를 진행합니다.
발표 자료는 전화 시작 이전에 회사의 투자자 관계 웹사이트에서 확인할 수 있습니다. 컨퍼런스콜의 재방송은 투자자 관계 웹사이트 ir.bauschhealth.com에서도 이용 가능합니다.
Bausch Health (NYSE:BHC) a prévu l'annonce des résultats financiers du troisième trimestre 2025 pour le 29 octobre 2025, après la clôture du marché. L'entreprise animera une conférence téléphonique et une webcast à 17 h 00, heure avancée américaine (EDT), pour discuter des résultats et fournir une mise à jour sur les activités.
Tous les documents de présentation seront disponibles sur le site des Relations avec les investisseurs de l'entreprise avant le début de l'appel. Une rediffusion de la conférence téléphonique sera également accessible via le site des relations avec les investisseurs à ir.bauschhealth.com.
Bausch Health (NYSE:BHC) hat die Ergebnisse des dritten Quartals 2025 für den 29. Oktober 2025 nach Börsenschluss terminiert. Das Unternehmen wird einen Conference Call und einen Webcast um 17:00 Uhr US-EDT abhalten, um die Ergebnisse zu besprechen und ein Update zum Geschäft zu geben.
Alle Präsentationsunterlagen werden vor Beginn der Telefonkonferenz auf der Investor-Relations-Website des Unternehmens verfügbar sein. Eine Wiederholung der Konferenz ist ebenfalls über die Investor-Relations-Website unter ir.bauschhealth.com zugänglich.
Bausch Health (NYSE:BHC) قد حددت الإعلان عن نتائج الربع الثالث من عام 2025 ليكون في 29 أكتوبر 2025, بعد إغلاق السوق. ستعقد الشركة مكالمة مؤتمرات وبثًا حيًا عبر الويب في الساعة 5:00 مساءً بتوقيت شرق الولايات المتحدة EDT لمناقشة النتائج وتقديم تحديث تجاري.
ستكون جميع مواد العرض متاحة على موقع علاقات المستثمرين للشركة قبل بدء المكالمة. كما سيكون بإمكان المستخدمين إعادة تشغيل المكالمة من خلال موقع علاقات المستثمرين على ir.bauschhealth.com.
Bausch Health (NYSE:BHC) 已安排于 2025 年 10 月 29 日美股收盘后公布其第 3 季度 2025 年财报。公司将于 美国东部夏令时 5:00 p.m. 举行电话会议和网络广播,讨论业绩并提供业务更新。
所有演示材料将在电话会议开始前在公司投资者关系网站上提供。电话会议的回放也可通过投资者关系网站 ir.bauschhealth.com 访问。
- None.
- None.
LAVAL, QC / ACCESS Newswire / September 30, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) will release third quarter 2025 financial results after market close on Wednesday, October 29, 2025. Bausch Health will host a live conference call and webcast at 5:00 p.m. U.S. EDT to discuss results and provide a business update. All materials will be made available on the Investor Relations section of the Bausch Health website prior to the start of the call.
Conference Call Details
Date: | Wednesday, October 29, 2025 |
Time: | 5:00 p.m. U.S. EDT |
Webcast: |
A replay of the conference call will be available on the investor relations website.
About Bausch Health
Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) is a global diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neurology, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors. For more information, visit www.bauschhealth.com and connect with us on LinkedIn.
###
Investor Contact: | Media Contact: | |
Garen Sarafian | Katie Savastano | |
(877) 281-6642 (toll-free) | (908) 541-3785 |
SOURCE: Bausch Health Companies Inc.
View the original press release on ACCESS Newswire